Breckenridge Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRECKENRIDGE, and what generic and branded alternatives to BRECKENRIDGE drugs are available?
BRECKENRIDGE has forty-two approved drugs.
There are two tentative approvals on BRECKENRIDGE drugs.
Summary for Breckenridge
US Patents: | 0 |
Tradenames: | 41 |
Ingredients: | 41 |
NDAs: | 42 |
Patent Litigation for Breckenridge: | See patent lawsuits for Breckenridge |
PTAB Cases with Breckenridge as petitioner: | See PTAB cases with Breckenridge as petitioner |
Drugs and US Patents for Breckenridge
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breckenridge | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209583-002 | Sep 24, 2021 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Breckenridge | AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride | TABLET;ORAL | 216243-006 | Jun 6, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Breckenridge | ARIPIPRAZOLE | aripiprazole | TABLET;ORAL | 091279-002 | Jan 9, 2017 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Breckenridge | ASENAPINE MALEATE | asenapine maleate | TABLET;SUBLINGUAL | 205960-001 | Dec 10, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Breckenridge | POMALIDOMIDE | pomalidomide | CAPSULE;ORAL | 210111-004 | Oct 30, 2020 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for BRECKENRIDGE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.